Mark H. Rapaport, MD

When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?

August 6, 2026

Focuses on descriptive symptom phenomenology and strategies to minimize discomfort during antidepressant cessation, with possible explanations for unusual, delayed, or protracted symptoms in patients for whom non-pharmacodynamic features may...

Joseph F. Goldberg, M. Lynn Crismon, David W. Goodman, et al

In Memoriam

Who Was Lori Altshuler?

March 23, 2016

Read about Lori Altshuler's life and how she effected psychiatry throughout her life.

Mark H. Rapaport

Original Research

The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders: A Post Hoc Analysis

November 15, 2013

Kimberly A. Yonkers, Michael E. Thase, David J. Kupfer, et al

Article

Teaching the Teacher: A Report From the Third Annual American Society of Clinical Psychopharmacology Teaching Session

March 15, 2013

Ira D. Glick, Sidney Zisook, Mark H. Rapaport

Original Research

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

December 15, 2012

David Mischoulon, Maurizio Fava, George I. Papakostas, et al

Article

New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists

April 15, 2012

John M. Kane, Bruce J. Kinon, William Z. Potter, et al

ASCP Corner

Omega-3 Fatty Acids and Depression: From Cellular Mechanisms to Clinical Care

February 15, 2011

Marlene P. Freeman, Mark H. Rapaport

Original Research

A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder

November 15, 2006

David L. Dunner, Richard C. Shelton, Robert M. A. Hirschfeld, et al

Original Research

Posttraumatic Stress Disorder and Quality of Life: Results Across 64 Weeks of Sertraline Treatment

January 1, 2002

Cathryn M. Clary, Jean Endicott, Mark H. Rapaport

Original Research

An Open-Label, 12-Week Clinical and Sleep EEG Study of Nefazodone in Chronic Combat-Related Posttraumatic Stress Disorder

October 1, 2001

Sidney Zisook, Murray B. Stein, Mark H. Rapaport, et al

Article

Prevalence, Recognition, and Treatment of Comorbid Depression and Anxiety

January 11, 2001

Mark H. Rapaport

Original Research

Sertraline Treatment of Panic Disorder: Response in Patients at Risk for Poor Outcome

December 31, 2000

Cathryn M. Clary, Mark H. Pollack, Mark H. Rapaport, et al

When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?

Who Was Lori Altshuler?

The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders: A Post Hoc Analysis

Teaching the Teacher: A Report From the Third Annual American Society of Clinical Psychopharmacology Teaching Session

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists

Omega-3 Fatty Acids and Depression: From Cellular Mechanisms to Clinical Care

A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder

Posttraumatic Stress Disorder and Quality of Life: Results Across 64 Weeks of Sertraline Treatment

An Open-Label, 12-Week Clinical and Sleep EEG Study of Nefazodone in Chronic Combat-Related Posttraumatic Stress Disorder

Prevalence, Recognition, and Treatment of Comorbid Depression and Anxiety

Sertraline Treatment of Panic Disorder: Response in Patients at Risk for Poor Outcome

ELSEWHERE:

FOLLOW US:

Mark H. Rapaport, MD

When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?

Who Was Lori Altshuler?

The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders: A Post Hoc Analysis

Teaching the Teacher: A Report From the Third Annual American Society of Clinical Psychopharmacology Teaching Session

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists

Omega-3 Fatty Acids and Depression: From Cellular Mechanisms to Clinical Care

A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder

Posttraumatic Stress Disorder and Quality of Life: Results Across 64 Weeks of Sertraline Treatment

An Open-Label, 12-Week Clinical and Sleep EEG Study of Nefazodone in Chronic Combat-Related Posttraumatic Stress Disorder

Prevalence, Recognition, and Treatment of Comorbid Depression and Anxiety

Sertraline Treatment of Panic Disorder: Response in Patients at Risk for Poor Outcome

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles